OJRA  Vol.3 No.2 , May 2013
Flexofytol, a Purified Curcumin Extract, in Fibromyalgia and Gout: A Retrospective Study
Abstract: Flexofytol is a recently-purified curcumin extract administered as a food supplement with the indication for being “able to improve musculoskeletal flexibility and preserve articular function”. It is now marketed in Belgium, frequently used with success in daily clinical practice according to pharmacists, and also prescribed by general practitioners and rheumatologists for various painful conditions. The objective of this retrospective study was to evaluate the potential efficacy of the compound in fibromyalgia and gout from our practice from 2011-2012. Accordingly, the medical files of 116 patients (83 with a follow-up of 1 to 12 months) with fibromyalgia or gout who were treated with Flexofytol were analysed to determine whether they had benefited from this therapy or had experienced undesirable effects. Flexofytol provided a benefit in acute gout crisis and fibromyalgia. Interestingly, the clinical improvement was rapid (within 24 - 48 h), with good efficacy in gout. The benefit of Flexofytol was on different manifestations of pain rather than on the sleep disorders of fibromyalgia. Except for some occasional difficulties with tablet swallowing and transient diarrhoea, the treatment was well tolerated. In conclusion, Flexofytol appears to be an alternative to conventional treatment for fibromyalgia and gout.
Cite this paper: T. Appelboom and C. MsciBiost, "Flexofytol, a Purified Curcumin Extract, in Fibromyalgia and Gout: A Retrospective Study," Open Journal of Rheumatology and Autoimmune Diseases, Vol. 3 No. 2, 2013, pp. 104-107. doi: 10.4236/ojra.2013.32015.

[1]   C. Koosiriatt, S Linpisarn, D. Changsom, K. Chawansuntati and J. Wipasa, “Investigation of the Anti-Inflammatory Effect of Curcuma in Helicobacter Pylori Infected Patients,” International Immunopharmacology, Vol. 10, No. 7, 2010, pp. 815-817. doi:10.1016/j.intimp.2010.04.021

[2]   B. Chandran and A. Goel, “A Randomized Pilot Study to Assess the Efficacy and the Safety of Curcumin in Patients with Active Rheumatoid Arthritis,” Phytotherapy Research, Vol. 26, No. 11, 2012, pp. 1719-1725. doi:10.1002/ptr.4639

[3]   A. S. Strimpakos and R. A. Sharma, “Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials,” Antioxidants & Redox Signaling, Vol. 10, No. 3, 2008, pp. 511-545. doi:10.1089/ars.2007.1769

[4]   T. Kawamori, R. Lubet, V. Steele, et al., “Chemopreventive Effect of Curcumin a Naturally Occurring Anti-Inflammatory Agent during the Promotion/Progression Stages of Colon Cancer,” Cancer Research, Vol. 59, No. 3, 1999, pp. 597-601.

[5]   T. Jida, K. Takeuchi, F. Watanabe, et al., “Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial,” Clinical Gastroenterology and Hepatology, Vol. 4, No. 2, 2006, pp. 1502-1506. doi:10.1016/j.cgh.2006.08.008

[6]   T. Hamaguchi, K. Ono and M. Yamada, “Review: Curcumin and Alzheimer’s Disease,” CNS and Neurosciences and Therapeutics, Vol. 16, No. 5, 2010, pp. 285-297. doi:10.1111/j.1755-5949.2010.00147.x

[7]   B. Y. Kang, Y. J. Song, K. M. Kim, Y. K. Choe, S. Y. Hwang and T. S. Kim, “Curcumin Inhibits Th1 Cytokine Profile in CD4+ T Cells by Suppressing IL-12 Production in Macrophages,” British Journal of Pharmacology, Vol. 128, No. 2, 1999, pp. 380-384. doi:10.1038/sj.bjp.0702803

[8]   M. Mathy, I. Jacquemond-Collet, F. Priem, C. Sanchez, C. Lambert and Y. Henrotin, “Curcumin Inhibits Proinflammatory Mediators and Metalloproteinase-3 Production by Chondrocytes,” Inflammation Research, Vol. 58, No. 12, 2009, pp. 899-908. doi:10.1007/s00011-009-0063-1

[9]   V. P. Menon and A. R. Sudheer, “Antioxidant and Anti-Inflammatory Properties of Curcumin,” Advances in Experimental Medicine and Biology, Vol. 595, 2007, pp. 105-125. doi:10.1007/978-0-387-46401-5_3

[10]   N. Chainani-Wu, “Safety and Anti-Inflammatory Activity of Curcumin a Component of Tumerin (Curcuma longa),” The Journal of Alternative and Complementary Medicine, 2003 Vol. 9, No. 1, 2003, pp. 161-168. doi:10.1089/107555303321223035

[11]   H. Hatcher, R. Planalp, J. Cho, F. Torti and S. V. Torti, “Curcumin: From Ancient Medicine to Current Clinical Trials,” Cellular and Molecular Life Sciences, Vol. 65, No. 11, 2008, pp. 1631-1652. doi:10.1007/s00018-008-7452-4

[12]   B. B. Aggarwal and K. B. Harikumar, “Potential Therapeutic Effects of Curcumin, the Anti-Inflammatory Agent, against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases,” The International Journal of Biochemistry & Cell Biology, Vol. 41, No. 1, 2009, pp. 40-59. doi:10.1016/j.biocel.2008.06.010